Alimentary Pharmacology & Therapeutics

The genetics of inflammatory bowel disease
pp. 731-748(18)
Authors: Ahmad, T.; Satsangi, J.; Mcgovern, D.; Bunce, M.; Jewell, D. P.

The therapy of constipation
pp. 749-763(15)
Author: Schiller, L. R.

Acid suppression in the management of gastro-oesophageal reflux disease—an appraisal of treatment options in primary care
pp. 765-772(8)
Authors: Jones, R.; Bytzer, P.

Guidelines for adults on self-medication for the treatment of acute diarrhoea
pp. 773-782(10)
Authors: Wingate, D.; Phillips, S. F.; Lewis, S. J.; Malagelada, J.-R.; Speelman, P.; Steffen, R.; Tytgat, G. N. J.

Abnormal bone turnover in long-standing Crohn's disease in remission
pp. 783-792(10)
Authors: Schoon, E. J.; Geerling, B. G.; Van Dooren, I. M. A.; Schurgers, L. J.; Vermeer, C.; Brummer, R.-J. M.; Stockbrügger, R. W.

Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes
pp. 793-803(11)
Authors: Horai, Y.; Kimura, M.; Furuie, H.; Matsuguma, K.; Irie, S.; Koga, Y.; Nagahama, T.; Murakami, M.; Matsui, T.; Yao, T.; Urae, A.; Ishizaki, T.

The effect of Helicobacter pylori eradication therapy on dyspepsia symptoms in industrial workers in Japan
pp. 805-811(7)
Authors: Azuma, T.; Ito, Y.; Suto, H.; Ohtani, M.; Dojo, M.; Muramatsu, A.; Kuriyama, M.; Kato, T.

Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis
pp. 813-820(8)
Authors: Koike, T.; Ohara, S.; Sekine, H.; Iijima, K.; Kato, K.; Toyota, T.; Shimosegawa, T.

Occurrence and relapse of bleeding from duodenal ulcer: respective roles of acid secretion and Helicobacter pylori infection
pp. 821-829(9)
Authors: Capurso, G.; Annibale, B.; Osborn, J.; D'Ambra, G.; Martino, G.; Lahner, E.; Delle Fave, G.

Anti-inflammatory and tissue-protectant drug effects: results from a randomized placebo-controlled trial of gastritis patients at high risk for gastric cancer
pp. 831-841(11)
Authors: Fischbach, L. A.; Correa, P.; Ramirez, H.; Realpe, J. L.; Collazos, T.; Ruiz, B.; Bravo, L. E.; Bravo, J. C.; Casabon, A. L.; Schmidt, B. A.

Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study
pp. 843-849(7)
Authors: Wong, B. C. Y.; Wang, W. H.; Wong, W. M.; Lau, G. K. K.; Fung, F. M. Y.; Kung, N. N. S.; Chu, K. M.; Lai, K. C.; Hu, W. H. C.; Hu, F. L.; Liu, X. G.; Chan, C. K.; Yuen, M. F.; Hui, W. M.; Lam, S. K.

Fish oil (Eicosapen) is less effective than metronidazole, in combination with pantoprazole and clarithromycin, for Helicobacter pylori eradication
pp. 851-855(5)
Authors: Meier, R.; Wettstein, A.; Drewe, J.; Geiser, H. R.

Bolus somatostatin but not octreotide reduces hepatic sinusoidal pressure by a NO-independent mechanism in chronic liver disease
pp. 857-864(8)
Authors: Matrella, E.; Valatas, V.; Notas, G.; Roumpaki, H.; Xidakis, C.; Hadzidakis, A.; Mouzas, I.; Kouroumalis, E.

Pioglitazone, a specific PPAR-γ ligand, inhibits aspirin-induced gastric mucosal injury in rats
pp. 865-873(9)
Authors: Naito, Y.; Takagi, T.; Matsuyama, K.; Yoshida, N.; Yoshikawa, T.

Involvement of cyclooxygenase-2 in hyperplastic gastritis induced by Helicobacter pylori infection in C57BL/6 mice
pp. 875-886(12)
Authors: Xiao, F.; Furuta, T.; Takashima, M.; Shirai, N.; Hanai, H.